BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 1346250)

  • 1. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
    Nieminen MS; Mattila KJ; Aalto-Setälä K; Kuusi T; Kontula K; Kauppinen-Mäkelin R; Ehnholm C; Jauhiainen M; Valle M; Taskinen MR
    Arterioscler Thromb; 1992 Jan; 12(1):58-69. PubMed ID: 1346250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
    Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C
    Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
    Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A
    Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration.
    Wile DB; Barbir M; Gallagher J; Myant NB; Ritchie CD; Thompson GR; Humphries SE
    Atherosclerosis; 1989 Jul; 78(1):9-18. PubMed ID: 2569310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.
    Frikke-Schmidt R; Nordestgaard BG; Agerholm-Larsen B; Schnohr P; Tybjaerg-Hansen A
    J Lipid Res; 2000 Nov; 41(11):1812-22. PubMed ID: 11060351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
    Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
    Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.
    Meyer E; Westerveld HT; de Ruyter-Meijstek FC; van Greevenbroek MM; Rienks R; van Rijn HJ; Erkelens DW; de Bruin TW
    Atherosclerosis; 1996 Aug; 124(2):221-35. PubMed ID: 8830935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remnant-like particle cholesterol levels in Korean patients with coronary artery disease and non-insulin dependent diabetes mellitus.
    Song J; Park H; Hong SH; Lee HK; Park YB; Kim JQ
    Clin Chem Lab Med; 2000 May; 38(5):427-32. PubMed ID: 10952226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
    Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
    Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
    Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
    Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease.
    Ford ES; Cooper RS; Simmons B; Castaner A
    J Clin Epidemiol; 1990; 43(5):425-32. PubMed ID: 2109048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.
    Azizi F; Rahmani M; Raiszadeh F; Solati M; Navab M
    Coron Artery Dis; 2002 Feb; 13(1):9-16. PubMed ID: 11917194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease.
    Kukita H; Hamada M; Hiwada K; Kokubu T
    Atherosclerosis; 1985 May; 55(2):143-9. PubMed ID: 3924067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism.
    Starck M; Schiele F; Herbeth B; Vincent-Viry M; Beaud B; Siest G; Visvikis S
    Atherosclerosis; 2001 Apr; 155(2):509-16. PubMed ID: 11254923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.